Delcath Systems Reports Second Quarter 2022 Results and Prov

/PRNewswire/ -- Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the...

Related Keywords

Germany , United States , United Kingdom , American , Gerard Michel , American Society Of Clinical Oncology , Prnewswire Delcath Systems Inc , Drug Administration , Nasdaq , Exchange Commission , Access Program , Delcath Systems Inc , American Society , Clinical Oncology , Expanded Access Program , Predictive Parameters , Unresectable Liver Metastases , Uveal Melanoma , Retrospective Pooled Analysis , Interventional Radiology , Hepatic Delivery System , Hepzato Kit , Chief Executive Officer , Sheet Highlights , Common Stock , Pre Funded Warrants , Private Placement , Monday August , Toll Free , Delcath Systems , United States Food , Delivery System , Private Securities Litigation Reform Act , Individual Funding Requests , Stockholder Equity , Consolidated Statements , Nc ,